(2S,5R)-tert-butyl 2-(4-aminobenzyl)-5-((R)-(3-fluorophenyl)(hydroxy)methyl)pyrrolidine-1-carboxylate | 1558057-73-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: (2S,5R)-tert-butyl 2-(4-aminobenzyl)-5-((R)-(3-fluorophenyl)(hydroxy)methyl)pyrrolidine-1-carboxylate
• 英文别名: tert-butyl (2S,5R)-2-[(4-aminophenyl)methyl]-5-[(R)-(3-fluorophenyl)-hydroxymethyl]pyrrolidine-1-carboxylate
• CAS: 1558057-73-0
• 化学式: C₂₃H₂₉FN₂O₃
• 分子量: 400.493
• InChiKey: HZFKZKTWKUAQCW-PWRODBHTSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  29
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  75.8
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-((tert-butoxycarbonyl)amino)-5,6-dihydro-4H-cyclopenta[d]thiazole-4-carboxylic acid 、 (2S,5R)-tert-butyl 2-(4-aminobenzyl)-5-((R)-(3-fluorophenyl)(hydroxy)methyl)pyrrolidine-1-carboxylate 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三氟乙酸 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 6.0h， 生成 (R)-2-amino-N-(4-(((2S,5R)-5-((R)-(3-fluorophenyl)(hydroxy)-methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6-dihydro-4H-cyclopenta[d]thiazole-4-carboxamide
  参考文献：
  名称：

  Design, Synthesis, and Evaluation of Conformationally Restricted Acetanilides as Potent and Selective β₃Adrenergic Receptor Agonists for the Treatment of Overactive Bladder

  摘要：

  A series of conformationally restricted acetanilides were synthesized and evaluated as beta(3)-adrenergic receptor agonists (beta(3)-AR) for the treatment of overactive bladder (OAB). Optimization studies identified a five-membered ring as the preferred conformational lock of the acetanilide. Further optimization of both the aromatic and thiazole regions led to compounds such as 19 and 29, which have a good balance of potency and selectivity. These compounds have significantly reduced intrinsic clearance compared to our initial series of pyridylethanolamine beta(3)-AR agonists and thus have improved unbound drug exposures. Both analogues demonstrated dose dependent beta(3)-AR mediated responses in a rat bladder hyperactivity model.

  DOI：

  10.1021/jm4017224
• 作为产物：
  描述：

  4-methoxybenzyl ((1R,2R)-1-((tert-butyldimethylsilyl)oxy)-1-(3-fluorophenyl)-6-(4-nitrophenyl)-5-oxohexan-2-yl)carbamate 在 palladium 10% on activated carbon 、 四丁基氟化铵 、 氢气 、 三乙酰氧基硼氢化钠 、 N,N-二异丙基乙胺 、 三氟乙酸 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 为溶剂， 反应 25.5h， 生成 (2S,5R)-tert-butyl 2-(4-aminobenzyl)-5-((R)-(3-fluorophenyl)(hydroxy)methyl)pyrrolidine-1-carboxylate
  参考文献：
  名称：

  Design, Synthesis, and Evaluation of Conformationally Restricted Acetanilides as Potent and Selective β₃Adrenergic Receptor Agonists for the Treatment of Overactive Bladder

  摘要：

  A series of conformationally restricted acetanilides were synthesized and evaluated as beta(3)-adrenergic receptor agonists (beta(3)-AR) for the treatment of overactive bladder (OAB). Optimization studies identified a five-membered ring as the preferred conformational lock of the acetanilide. Further optimization of both the aromatic and thiazole regions led to compounds such as 19 and 29, which have a good balance of potency and selectivity. These compounds have significantly reduced intrinsic clearance compared to our initial series of pyridylethanolamine beta(3)-AR agonists and thus have improved unbound drug exposures. Both analogues demonstrated dose dependent beta(3)-AR mediated responses in a rat bladder hyperactivity model.

  DOI：

  10.1021/jm4017224

文献信息

• Design, Synthesis, and Evaluation of Conformationally Restricted Acetanilides as Potent and Selective β₃Adrenergic Receptor Agonists for the Treatment of Overactive Bladder
  作者：Christopher R. Moyes、Richard Berger、Stephen D. Goble、Bart Harper、Dong-Ming Shen、Liping Wang、Alka Bansal、Patricia N. Brown、Airu S. Chen、Karen H. Dingley、Jerry Di Salvo、Aileen Fitzmaurice、Loise N. Gichuru、Amanda L. Hurley、Nina Jochnowitz、Randall R. Miller、Shruty Mistry、Hiroshi Nagabukuro、Gino M. Salituro、Anthony Sanfiz、Andra S. Stevenson、Katherine Villa、Beata Zamlynny、Mary Struthers、Ann E. Weber、Scott D. Edmondson

  DOI：10.1021/jm4017224

  日期：2014.2.27

  A series of conformationally restricted acetanilides were synthesized and evaluated as beta(3)-adrenergic receptor agonists (beta(3)-AR) for the treatment of overactive bladder (OAB). Optimization studies identified a five-membered ring as the preferred conformational lock of the acetanilide. Further optimization of both the aromatic and thiazole regions led to compounds such as 19 and 29, which have a good balance of potency and selectivity. These compounds have significantly reduced intrinsic clearance compared to our initial series of pyridylethanolamine beta(3)-AR agonists and thus have improved unbound drug exposures. Both analogues demonstrated dose dependent beta(3)-AR mediated responses in a rat bladder hyperactivity model.